Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-02-28

Clinical Trial Update: Observational, Real-life, Retrospective, Data Collection, Use Sibutramine/topiramate in Overweight Comorbidities/obesity

View source ↗

Summary

A clinical trial evaluating the combination of sibutramine and topiramate for overweight/obesity in an observational retrospective data collection has been with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sibutramine (sibutramine)
  • Topiramate (Topiramate)

Snippet

Sponsor: Eurofarma Laboratorios S.A. | Conditions: Overweight, Obesity | Status: WITHDRAWN